Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study

Michelle C Williams1, Alastair J Moss2, Marc Dweck1

  • 1University of Edinburgh/British Heart Foundation Centre for Cardiovascular Science, Edinburgh, United Kingdom; Edinburgh Imaging Facility QMRI, University of Edinburgh, Edinburgh, United Kingdom.

Insights

Adverse coronary plaque features identified by coronary computed tomography angiography significantly increase the risk of coronary heart disease events. This highlights the prognostic value of plaque characterization in patients with suspected coronary artery disease.

Area of Science:

  • Cardiovascular Imaging
  • Radiology
  • Preventive Cardiology

Background:

  • Coronary computed tomography angiography (CCTA) offers advanced capabilities in characterizing atherosclerotic plaque subtypes, unlike many other noninvasive imaging methods.
  • Understanding the prognostic implications of specific plaque characteristics is crucial for risk stratification in patients with suspected coronary artery disease.

Purpose of the Study:

  • To investigate the prognostic significance of adverse coronary plaque characteristics in patients suspected of having coronary artery disease.
  • To assess the association between plaque features, obstructive disease, and coronary artery calcification with cardiovascular events.

Main Methods:

  • A post hoc analysis of the SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) involving 1,769 patients followed for 5 years.
  • Coronary computed tomography angiography was used to assess adverse plaque (positive remodeling, low attenuation), obstructive disease, and coronary artery calcification in 15 coronary segments.
  • Outcomes included coronary heart disease death or nonfatal myocardial infarction.

Main Results:

  • Patients with adverse plaque features (34%) had a 3-fold higher risk of coronary heart disease death or nonfatal myocardial infarction compared to those without.
  • Obstructive disease was associated with a 2-fold increased risk of these events.
  • The highest event rate (10-fold increase) was observed in patients with both obstructive disease and adverse plaque, though associations were not independent of coronary artery calcium score.

Conclusions:

  • Adverse coronary plaque characteristics and overall calcified plaque burden are significant indicators of increased risk for coronary heart disease death or nonfatal myocardial infarction.
  • CCTA-derived plaque characterization provides valuable prognostic information beyond traditional risk factors and calcification assessment.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
426
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.7K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
368
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
684